|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/00 | (2006.01) |
| A61K 9/0014 | (2013.01) | ||
| A61K 9/06 | (2006.01) | ||
| A61K 47/02 | (2013.01) | ||
| A61K 9/12 | (2006.01) | ||
| A61K 9/06 | (2013.01) | ||
| A61K 38/22 | (2006.01) | ||
| A61K 38/2292 | (2013.01) | ||
| A61K 47/18 | (2006.01) | ||
| A61K 47/38 | (2013.01) | ||
| A61K 47/26 | (2006.01) | ||
| A61K 47/32 | (2013.01) | ||
| A61K 47/10 | (2006.01) | ||
| A61K 47/32 | (2006.01) | ||
| A61K 47/38 | (2006.01) | ||
| A61K 47/02 | (2006.01) |
| (11) | Patento numeris | 3590497 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17899160.0 |
| Europos patento paraiškos padavimo data | 2017-08-04 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-01-08 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-03-29 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/KR2017/008442 |
| Data | 2017-08-04 |
| (87) | Numeris | WO 2018/159906 |
| Data | 2018-09-07 |
| (30) | Numeris | Data | Šalis |
| 20170027706 | 2017-03-03 | KR |
| (72) |
CHOI, Jun Won , KR
KIM, Kyoungsun , KR
LEE, Si Young , KR
UM, Tae Heum , KR
|
| (73) |
HLB Therapeutics Co., Ltd. ,
22F, 248 Jeongjail-ro
Bundang-gu, Seongnam-si, Gyeonggi-do 13554,
KR
|
| (54) | STABILIZED EXTERNAL USE AGENT COMPRISING THYMOSIN BETA-4 AS EFFECTIVE INGREDIENT |
| STABILIZED EXTERNAL USE AGENT COMPRISING THYMOSIN BETA-4 AS EFFECTIVE INGREDIENT |